H.R. 1266

Combating Illicit Xylazine Act

Judiciary Committee, Energy and Commerce Committee · Rep. Jimmy Panetta (D-CA)

The bill would classify xylazine, a veterinary sedative increasingly found mixed with fentanyl in illegal drugs, as a controlled substance under federal law. This would make manufacturing and distributing it illegally subject to criminal penalties, require tracking of xylazine transactions, and exempt legitimate veterinary and animal-control uses; the measure also directs federal agencies to study and report on the extent of illicit xylazine use and trafficking.[AI-Generated]

Reported by committee 14 September 2026

Record as of 14 September 2026 — the most recent action in the official record. Status can lag; each step below carries its own date.

14 September 2026 Reported by committee
What's next: Floor scheduling - the bill went to more than one committee (leadership decides if and when it gets a vote)
14 September 2026 Placed on calendar (House)
14 September 2026 Discharged from committee
5 more actions
1. 21 July 2026 Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.
2. 21 July 2026 Committee Consideration and Mark-up Session Held
3. 20 July 2026 Committee Consideration and Mark-up Session Held
4. 25 June 2026 Forwarded by Subcommittee to Full Committee by Voice Vote.
5. 25 June 2026 Subcommittee Consideration and Mark-up Session Held
12 February 2025 Referred to the Subcommittee on Health
12 February 2025 Referred to committee
12 February 2025 Introduced in House

This path starts where the bill does — its first action in the official record. Routine procedural steps sit in the “more actions” rows above rather than on the main line.

Read the live feed — on the site or in the app Look up H.R. 1266 on Congress.gov All US bills